Kubota Pharmaceutical Holdings Co., Ltd. reported earnings results for the half year ended June 30, 2023. For the half year, the company reported sales was JPY 17.23 million. Net loss was JPY 744.69 million compared to JPY 1,196.84 million a year ago.

Basic loss per share from continuing operations was JPY 13.48 compared to JPY 26.02 a year ago. Diluted loss per share from continuing operations was JPY 13.48 compared to JPY 26.02 a year ago.